2 minute read

Legal Matters

Next Article
Oncology Research

Oncology Research

Legal Matters No Steak, No Wine? OIG Cautions Against Physician Speaker Programs

By Asher D. Funk, J.D. Dayna C. Laplante, J.D. Polsinelli, PC

Advertisement

In a recent Special Fraud, the Department of Health and Human Services Office of Inspector General (HHS-OIG) raised significant fraud and abuse concerns with companies offering or providing remuneration in connection with physician speaker programs. Speaker programs typically involve one health care professional presenting to others on a company’s drug or device, or a disease state relevant to the company’s products, in exchange for a speaker honorarium. While speaker programs may have some legitimate purposes, HHS-OIG warned of risk the programs create, if one purpose is to induce or reward federal health care program referrals.

Because the HHS-OIG rarely issues Special Fraud Alerts and has not done so in over six years, this guidance warrants the attention of health care providers along with a review of health care entities’ current practices.

In the Fraud Alert, HHS-OIG identified the following non-exhaustive list of “suspect characteristics,” which may be present in speaker programs and increase the risk of liability under the Anti-Kickback Statute: • Little or no substantive information is presented at a company-sponsored speaker program; • Alcohol is available or free, or a meal greater than modest value is provided to attendees; • The program’s setting is not conducive to the exchange of educational information (e.g. restaurants, sports or entertainment venues); A company sponsors a large number of programs on the same or similar topic, particularly where there is no recent substantive change in relevant information; No new medical or scientific information, or a new FDA-approved or clear indication for the product, has occurred in a significant period of time; Health care professionals attend the same or substantially similar programs more than once; Program attendees do not have a legitimate business reason to attend (e.g. significant others of the health care professional attendee, employees of the speaker’s medical practice, others with no use for the information, etc.); Sales or marketing personnel influence the selection of speakers or the company selects speakers or attendees based on past or expected revenue they will generate by ordering company products; and, Compensation the company pays health care professionals for speaking is more than fair market value or takes into account the volume or value of past or potential business generated.

HHS-OIG emphasized in the Fraud Alert that many investigations and enforcement actions under the federal False Claims Act and Anti-Kickback Statute included one or more of the characteristics listed above. HHS-OIG also acknowledged the nearly $2 billion that drug and device companies reported as being paid to physicians for speaker-related services in the last three years. A recent settlement between Medtronic USA Inc. and the Department of Justice highlights these enforcement efforts and the importance of properly

see Legal Matters...page 14

This article is from: